Palm Beach Research Center   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: West Palm Beach FL United States (1994)
Status: Defunct (2022)

Organization Overview

First Clinical Trial
2006
NCT00332956
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Palm Beach CRO | Palm Beach Research | Palm Beach Research Center

Active Ingredients

Drugs in Phase 4 Trials (1)

capsaicin (qutenza) (1 trial)

Drugs in Phase 3 Trials (3)

betamethasone (celestone) (1 trial)

calcipotriene (dovonex) (1 trial)

ibuprofen (motrin) (1 trial)

Drugs in Phase 2 Trials (2)

peramivir (rapivab) (1 trial)

rf1v vaccine (1 trial)

Drugs in Phase 1 Trials (1)

sq001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Plague (Phase 2)

Psoriasis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 7